Patriot Scientific

Patriot Scientific Reports Profitable Quarter; Q3 FY '08 Net Income $6.3 Million or $0.02 Basic and Diluted Earnings Per Share.
in response to mikesmark's message

Thanks for posting this information. It reveals more of what has really been going on behind the scene. I think it's fantastic that the info is now in front of the court in a legal document.

I also found the remarks of Otteson to be interesting because he still ( even if he was trying to escape this tangled mess) is involved.

Meanwhile, to further leverage its position, in August 2015 Alliacense wrote to our former patent litigation counsel, Jim Otteson, Esq., objecting to any of the Work Product once in
Baumgardner law firm. A true and correct copy of Alliacense's letter to Mr.Otteson dated August 26, 2015, is attached hereto asExhibit “
Q
Further it goes on:

In response to Alliacense’s demands, Mr. Otteson advised Alliacense that the Work Product could not be considered “Alliacense Proprietary Materials ” because it was actually created
by Alliacense a vendor for PDS in connection with efforts to enforce rights under the MMP Portfolio. As such, the Work Product is owned by TPL/PDS. Attached hereto and marked as Exhibit “R” is a true and correct copy of Mr. Otteson’s letter to Alliacence dated September 10,
2015

Please login to post a reply
bankerson
City
Rank
Vice President
Activity Points
21999
Rating
Your Rating
Date Joined
02/17/2005
Social Links
Private Message
Patriot Scientific
Symbol
PTSC
Exchange
OTCBB
Shares
401,392,948
Industry
Technology & Medical
Website
Create a Post